MSCI vs PBYI · P/E 37, rev $1.72B vs P/E 4.3, rev $56.5M
MSCI Inc (MSCI) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
MSCI currently screens at market cap $46.82B and trailing P/E 36.8. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the MSCI and PBYI stock pages for the full models.
Not investment advice.